Myelitis as a side effect of tofersen therapy in SOD1-associated ALS

J Neurol. 2024 Apr;271(4):2114-2118. doi: 10.1007/s00415-023-12130-1. Epub 2023 Dec 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyotrophic Lateral Sclerosis* / drug therapy
  • Amyotrophic Lateral Sclerosis* / genetics
  • Humans
  • Mutation
  • Myelitis* / genetics
  • Oligonucleotides / adverse effects
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase-1 / antagonists & inhibitors
  • Superoxide Dismutase-1 / genetics

Substances

  • Oligonucleotides
  • SOD1 protein, human
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • tofersen